NCT07216443View on ClinicalTrials.gov

Reduced Intensity or Nonmyeloablative Conditioning With Orca-T for Acute Myelogenous Leukemia and Myelodysplastic Syndrome

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 7, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

December 31, 2028

Conditions
Leukemia, Myeloid, AcuteMyelodysplastic SyndromesMixed Phenotype Acute Leukemia
Interventions
BIOLOGICAL

Orca-T

An allogeneic stem cell and T-cell immunotherapy biologic

Trial Locations (4)

37221

NOT_YET_RECRUITING

Vanderbilt University Medical Center, Nashville

90095

RECRUITING

UCLA Department of Medicine, Los Angeles

97239

NOT_YET_RECRUITING

Oregon Health and Science University, Portland

07601

NOT_YET_RECRUITING

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Sponsors
All Listed Sponsors
lead

Orca Biosystems, Inc.

INDUSTRY